David S. Kabakoff, Ph.D.
Executive-in-Residence
Sofinnova Ventures

Dr. Kabakoff has served as a member of the Board since November 2005. Dr. Kabakoff has served as Executive-in-Residence of Sofinnova Ventures from May 2007 to the present. He has also served as President and Chief Executive Officer of Strategy Advisors, LLC, a consulting company, from August 2000 to the present. From January 2001 to June 2005, when it was acquired by Cephalon, Inc., a biotechnology company, Dr. Kabakoff served as the founder, Chairman and Chief Executive Officer of Salmedix, Inc., a biotechnology company. From May 1996 to August 2000, Dr. Kabakoff served in senior executive positions at Dura Pharmaceuticals Inc., a specialty pharmaceuticals company that was acquired by Elan Pharmaceuticals. Dr. Kabakoff is a member of the board of directors of Avalon Pharmaceuticals, Inc. He also serves on the boards of directors of several private companies. Dr. Kabakoff holds a B.A. in Chemistry from Case Western Reserve University and a Ph.D. in Chemistry from Yale University.